insights_auto
Why is AGIO down 3.23%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.76
arrow_downward
-3.23%(-1.06) 1D
$31.76
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 12, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$32.56
High
$32.76
Low
$31.56
Mkt. cap
1.90B
Avg. vol.
1.29M
Volume
497.04K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$32.56
High
$32.76
Low
$31.56
Mkt. cap
1.90B
Avg. vol.
1.29M
Volume
497.04K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
Stocktwits
·
13 minutes ago
S&P 500, Dow, Nasdaq Futures Recover After Markets End Lower On Jensen Huang’s Exit, Oil Price Pressure — CRWV, CBRS, NVDA, TSLA In Focus
Eurasia Business News
·
1 hour ago
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
Investing.com
·
3 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
Traders Union
·
2 hours ago
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc